article thumbnail

GLP-1s Add AFib To Their Benefits List

CardiacWire

It seems like every week were discovering a new GLP-1 cardiac benefit, with the TRANSFORM-AF study now suggesting the drug could help reduce AFib burden. have AFib, making it one of the more common cardiovascular conditions. Examining the effects of GLP-1s on AFib , researchers examined 2.5k Up to six million people in the U.S.

AFIB 59
article thumbnail

PFA or Cryoballoon for Paroxysmal AFib?

CardiacWire

Expanding the potential patient population for pulsed field ablation, results from the SINGLE SHOT CHAMPION study suggest PFA might be just as good as cryoballoon ablation for patients with paroxysmal AFib. The post PFA or Cryoballoon for Paroxysmal AFib? Atrial tachyarrhythmia recurred in 37.1% of the PFA group compared to 50.7%

AFIB 59
article thumbnail

New Data Available for Minimally Invasive Treatment of AFib

DAIC

18, 2024 — Abbott recently announced new data for the Amplatzer Amulet Left Atrial Appendage (LAA) Occluder to treat people with atrial fibrillation (AFib) who are at an increased risk of stroke. tim.hodson Tue, 11/19/2024 - 15:57 Nov.

AFIB 52
article thumbnail

AFib Might Be Far More Common Than We Think

CardiacWire

age, 54% women, 50% White), finding that a whopping 2M (6.8%) of them had been diagnosed with AFib. AFib rates increased dramatically during the study period, from 4.49% in 2005-2009 to 6.82% in 2015-2019. the researchers estimate that at least 10.55M Americans are currently diagnosed with AFib, representing 4.48% the U.S.

AFIB 105
article thumbnail

Afib Ablation Delivers in First Sham-Controlled Study

Med Page Today

(MedPage Today) -- LONDON -- Pulmonary vein isolation (PVI) produced real short-term improvements for people with atrial fibrillation (Afib or AF), according to the first sham-controlled trial on the subject. Continuous monitoring by implantable.

AFIB 121
article thumbnail

Serious Issues With Slow Heartbeat Flagged for Afib Patients on Antiarrhythmics

Med Page Today

(MedPage Today) -- Old concerns about the safety of rhythm control drugs for atrial fibrillation (Afib or AF) resurfaced in a contemporary large Korean population-based study. Afib patients prescribed antiarrhythmic drugs (AADs) had several-fold.

AFIB 130
article thumbnail

Study Shows Medtronic ICM Accurately Predicts Risk Thresholds for AFib Patients Using AI

DAIC

16, 2025 Primary results from the DEFINE AFib clinical study show the Medtronic LINQ family of insertable cardiac monitors (ICM), paired with a novel algorithm, were able to detect atrial fibrillation episodes and properly risk stratify patients as high risk prior to an AF-related healthcare utilization 80% of the time. Piccini, M.D.,

AFIB 52